New Year's Day? Home?
Release time:
2021-01-21
New Year on the spot? Go home for the New Year?
Recently, the cold wave hit, the national cooling, the domestic epidemic has a rising trend. First, Shenyang's old lady yin, who "ho ho" a city, denounced it on the internet. After that, there was a sudden "outbreak" in Shijiazhuang, Hebei province. since the beginning of January this year, a total of more than 400 new cases have been infected. in just over 10 days, the number of people infected in Hebei province when the epidemic was at its worst at the beginning of last year was exceeded. This has to be worrying. These are undoubtedly reminding us that the epidemic has not passed and we cannot relax our vigilance.
In another month, the Chinese New Year will be coming back. Looking at the momentum of this epidemic, I believe that most people, like me, are probably most concerned about "whether they can go home for the Chinese New Year this year or not".
I keep an eye on the relevant aspects of the Internet. Recently, many experts such as Zhong Nanshan and Zhang Boli have expressed their views on Spring Festival travel. In general: you can travel, but you must be measured, not as large-scale as the National Day, but not as motionless as last year's Spring Festival. But governments everywhere look more cautious than experts. Recently, many places have intensively issued the "New Year in Place" initiative, and the Wucheng People's Government has also issued the "Proposal for Staying in Wuwu for the New Year".
In my opinion, if you usually live together as a family, you must be very willing to cooperate with the initiative. However, some people have been away from home for a year and are looking forward to returning home for a few days during the Spring Festival. My father and mother also miss each other deeply and look forward to it. Some did not return last year, and it would be a bit cruel not to return this year. Therefore, for those who choose to celebrate the New Year in situ, I will give you some praise; those who really want to return can go home and reunite without violating the regulations. After all, everyone has their own situation. Although, my heart still hopes that everyone can be reunited with their families during the New Year.
There is still a month before the Spring Festival, the epidemic situation is changing, what will happen before the Spring Festival, it is hard to say, everything can only be known at that time. Last year, China paid a huge price to fight the epidemic, and finally controlled the epidemic. Now we really can't be careless, and we can't let the embankment of a thousand miles be destroyed by the ant nest.
In the face of a global epidemic, it's not just up to the country, it's up to each of us. Actively cooperate with local governments to make arrangements, abide by regulations, and take more precautions to prevent the outbreak from reigniting. Now that the vaccine has come out, it will take some time before universal vaccination can be achieved. Therefore, in the last period of time, please make joint efforts to isolate, wear masks, go out less if you can, always pay attention to epidemic prevention requirements, adjust your arrangements at any time, protect yourself, protect your family, and protect our country. (Cao Fangtao)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page